FFIV News 114.29 07/30/2014 05:02:50 F5 Networks (FFIV)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
F5 Networks (FFIV) 114.29 $FFIV

Watch for F5 Networks to Potentially Pullback After Gaining 2.18% Yesterday
Comtex SmarTrend(R) - Thu Jul 24, 3:42PM CDT
F5 Networks (NASDAQ:FFIV) traded in a range yesterday that spanned from a low of $112.32 to a high of $117.77. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $112.65 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

F5 Networks Rises 2.18% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Jul 24, 3:42PM CDT
F5 Networks (NASDAQ:FFIV) traded in a range yesterday that spanned from a low of $112.32 to a high of $117.77. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $112.65 on volume of 4.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

F5 Networks Seen Replacing Cisco For Key Product
at Investor's Business Daily - Thu Jul 24, 1:48PM CDT
F5 Networks (FFIV) posted fiscal Q3 earnings late Wednesday that beat estimates, as did its Q4 guidance, with an analyst saying an F5 networking product is often replacing a Cisco Systems rival product. F5 stock was up more than 2% in afternoon...

Facebook Soars on Strong Earnings: Tech Winners & Losers
at The Street - Thu Jul 24, 10:12AM CDT
Facebook shares took off on strong earnings, while AT&T shares fell on missed estimates and Nokia shares rose after earnings beat expectations.

Stocks Up And Down At Open; Under Armour, Facebook Surge
at Investor's Business Daily - Thu Jul 24, 9:31AM CDT
Stocks opened in a narrowly mixed stance Thursday. The Dow Jones industrial average and the S&P 500 inched up a fraction each. The Nasdaq dipped 0.1% as Qualcomm (QCOM), Celgene (CELG) and Alexion Pharmaceuticals (ALXN) dived after delivering...

Will These Analyst Upgrades Help F5 Networks (FFIV) Stock Today?
at The Street - Thu Jul 24, 8:40AM CDT
F5 Networks (FFIV) received a pair of price target increases on Thursday after the tech company's strong third-quarter results.

F5 Networks Beats on Q3 Earnings & Revenues, Guides Well - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:00AM CDT
F5 Networks Inc. (FFIV) reported third-quarter fiscal 2014 adjusted earnings of $1.07 per share, which not only beat the Zacks Consensus Estimate of $1.05 per share but also increased 23.1% on a year-over-year basis.

F5 Enhances Application Availability with VMware vCloud Hybrid Service
Business Wire - Thu Jul 24, 6:00AM CDT
F5 Networks (NASDAQ: FFIV) announced today that BIG-IP(R) application services are now available for VMware vCloud(R) Hybrid Service(TM), a secure, hybrid cloud service based on VMware vSphere(R). Enterprise customers can now easily extend the same impactful application delivery services they enjoy in the data center into the cloud. Specifically, global application availability, automation, and cloud bursting are enhanced with F5 and VMware, bolstering disaster recovery and business continuity efforts. Moreover, with today's announcement, F5 offers certified capabilities within vCloud Hybrid Service environments that few other Application Delivery Controller (ADC) vendors can match.

Moody's (MCO) Well Positioned to Beat Q2 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 3:30PM CDT
We expect Moody's, Inc. (MCO) to beat earnings expectations when it reports second-quarter fiscal 2014 results on Jul 25

F5 Networks Announces Results for Third Quarter of Fiscal 2014
Business Wire - Wed Jul 23, 3:07PM CDT
For the third quarter of fiscal 2014, F5 Networks, Inc. (NASDAQ: FFIV) announced revenue of $440.3 million, up 5 percent from $420.0 million in the prior quarter and 19 percent from $370.3 million in the third quarter of fiscal 2013.

Industry Veteran John Williams Joins Reduxio Systems as President
PR Newswire - Wed Jul 23, 10:00AM CDT
Reduxio Systems, a next-generation super-efficient hybrid storage innovator, announced today that John Williams has joined Reduxio as President to lead its field strategy and operations, building Reduxio's worldwide sales organization and channel business.

Will F5 Networks Inc. (FFIV) Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 8:00AM CDT
We expect F5 Networks Inc. (FFIV) to beat expectations when it reports third-quarter 2014 results on Jul 23.

Will Cirrus Logic (CRUS) Miss Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 6:34PM CDT
Cirrus Logic Inc. (CRUS) is set to report first-quarter fiscal 2015 results on Jul 23.

Will Pandora Media (P) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 1:40PM CDT
Pandora Media Inc. (P) is set to report second-quarter fiscal 2014 results on Jul 24, 2014.

Will Altera Corp. (ALTR) Beat Earnings Estimate this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 1:30PM CDT
We expect Altera Corp. (ALTR) to beat expectations when it reports second-quarter 2014 results on Jul 24.

Seven Industry-leading Stocks Reporting Earnings This Week
at The Street - Tue Jul 22, 9:54AM CDT
By James Dennin for Kapitall. Geopolitical strife kept stocks down through the morning on Monday, despite a stock rally where [...]

Partnerships, Successful Interoperability Tests, Recognitions, Preliminary Financial Results, and Product Certification - Analyst Notes on Citrix, F5, ADP, Interactive Intelligence and CA Technologies
PR Newswire - Tue Jul 22, 7:50AM CDT
Today, Analysts Review released its analysts' notes regarding Citrix (NASDAQ: CTXS), F5 Networks (NASDAQ: FFIV), ADP (NASDAQ: ADP), Interactive Intelligence Group Inc. (NASDAQ: ININ) and CA Technologies (NASDAQ: CA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4935-100free.

Why F5 Networks (FFIV) Might Surprise This Earnings Season - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 7:46AM CDT
F5 Networks (FFIV) looks poised to beat at earnings season. That is because F5 Networks is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

REMINDER: F5 Announces Date for Q3 Earnings Conference Call
Business Wire - Tue Jul 22, 6:31AM CDT
F5 Networks (NASDAQ: FFIV) announced today that company management will host a conference call to review financial results for the third quarter of fiscal year 2014 on Wednesday, July 23, 2014 at 1:30 p.m. PT.

Can EMC Corp. (EMC) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 5:30PM CDT
EMC Corporation (EMC) is set to report second quarter 2014 results on Jul 23, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 21

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 14

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 510

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 7

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 87

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 370

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
AI Agents Redefine Finance: Deutsche & Ant Tech

Updated Category News Views 16

AI Agents: Shaping the Future of Finance The finance world has always been about numbers and precision, but now, with the advent of AI, it’s entering a domain where machines could call the shots. Hold your horses before you imagine free-wheeling robots in suits; this is still the finance sector, where control and audits are holy grails. Deutsche Bank and Ant's Ambitious...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 490

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

TC BioPharm's Continued Trading Highlights Market Confidence

Updated Category News Views 156

TC BioPharm Continues to Trade On Nasdaq TC BioPharm (Holdings) PLC, recognized by the ticker symbol TCBP, is actively trading on the Nasdaq Global Select Market. This clinical-stage biotechnology company is notably focused on developing allogeneic gamma-delta T cell therapies, primarily targeting cancer and various other medical conditions. Sustained Trading Activity The...

Continue Reading
Innovative AI Partnership Enhances Retail Security Solutions

Updated Category News Views 65

RaptorVision and Veesion Unite for Retail Excellence In a significant development for the retail industry, RaptorVision and Veesion have announced a global strategic partnership. This collaboration merges Veesion’s advanced concealment detection behavioral analytics with RaptorVision’s AI Event-Based Product Engagement and Integration Platform tailored for the retail...

Continue Reading
ADM's Q2 2025 Financial Performance: Insights and Trends

Updated Category News Views 152

ADM's Financial Overview for Q2 2025 ADM Aéroports de Montréal has released its financial results for the second quarter of 2025. This comprehensive report encompasses passenger traffic data, revenue figures, and insights into ongoing capital investment projects at YUL Montréal-Trudeau International Airport. Key Highlights of the Q2 Results The second quarter of 2025...

Continue Reading
Octopus AIM VCT Welcomes New Non-Executive Director

Updated Category News Views 184

Octopus AIM VCT Announces a Strategic Appointment Octopus AIM VCT plc is thrilled to share the exciting news of David Docherty joining the team as an independent Non-Executive Director. His official start will follow the upcoming Annual General Meeting. This strategic move reflects the company's commitment to enhance its governance and leadership. A Wealth of Experience...

Continue Reading
Enhancing Cybersecurity: New Designation for Risk Management Pros

Updated Category News Views 177

Introducing the Associate in Cyber Risk Management Designation In today's digital age, cyber risks have become one of the most pressing challenges for organizations globally. An alarming number of C-level executives—87% according to a recent survey—acknowledge that their companies are not fully prepared to face potential cyberattacks. Recognizing this critical issue,...

Continue Reading